AI assistant
Sending…
KIORA PHARMACEUTICALS INC — Director's Dealing 2017
Nov 15, 2017
35256_dirs_2017-11-15_1d0a119e-157f-45d9-ab7d-8123046a1cd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: EYEGATE PHARMACEUTICALS INC (EYEG)
CIK: 0001372514
Period of Report: 2017-11-01
Reporting Person: Garanzini Michael (Chief Commercial Officer)
More from KIORA PHARMACEUTICALS INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 8
Interim / Quarterly Report
2026
May 8
Annual Report
2026
May 1
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Annual Report
2026
Mar 25